04/20/2026
The Funding Gap in Lyme Disease Research:
Lyme disease is one of the most common vector-borne illnesses in the United States, yet the amount of research funding dedicated to understanding and treating it remains strikingly low.
When we look at federal research funding on a per-patient basis, the disparity becomes even clearer.
Current estimates show that Lyme disease receives roughly $90 in federal research funding per patient.
To put this in perspective:
• West Nile virus receives about 75 times more funding per patient.
• Malaria receives approximately 1,300 times more funding per patient.
Despite the growing number of people affected by Lyme disease and other tick-borne infections, research funding has not kept pace with the scale and complexity of the illness.
Greater investment in research could help advance:
• improved diagnostic tools
• better treatment strategies
• a deeper understanding of persistent symptoms
• more effective prevention efforts
For the millions of people impacted by Lyme disease each year, increased research support is not just a policy issue, it’s a health issue.
Raising awareness about the funding gap is an important step toward improving care and outcomes for patients.